Two new medications will be available in the UAE this month. One of them is said to be a breakthrough drug involving diabetes therapy, whilst the other could decrease mortality in heart failure patients by 20%. Both drugs have been approved by the US Food and Drug Administration (FDA), and will be registered in the Emirates before the end of October. The UAE is the first country to introduce the said medicines in the MENA region. The news was announced by His Excellency Dr. Amin Al Amiri, Assistant Undersecretary for Public Health and Licensing at the UAE Ministry of Health at an ongoing pharmaceutical event in Dubai.

High-level Saudi delegation offers condolences to H.H. Sheikh Mohammed
Sharjah Police refutes reports of murder victim's family going missing
UAE condemns attacks in Ethiopia, urges de-escalation
UAE strengthens focus on early childhood, family wellbeing
17 tanks seized in Dubai for illegal waste disposal in first half of 2026
Dubai Municipality records over 2,000 violations in residential areas
UAE announces suspension of Iranian airlines' flights
Sheikh Abdullah discusses enhancing humanitarian response at UN
Saudi Crown Prince offers condolences to H.H. Sheikh Mohammed
UAE to equip one million Lebanese in AI skills under new partnership
10 million meals for Gaza in tribute to late Sheikh Ahmed bin Rashid
UAE steps up winter relief efforts for Gaza families
Sheikh Abdullah meets President of Ecuador on UNGA81 sidelines
Dubai Police trains school bus drivers and supervisors on student safety
H.H. Sheikh Mohammed receives condolences on passing of Sheikh Ahmed
UAE welcomes US statement on Sudan peace efforts
UAE among global leaders in nuclear security progress
Sharjah approves over AED17.8 million in debt settlement for citizens
Sheikh Abdullah joins Trump meeting on sidelines of UN General Assembly
